Spain Continuous Glucose Monitoring Market Size, Share, and COVID-19 Impact Analysis, By Device Component (Transmitters, Sensors, and Receivers), By End-use (Hospitals, Homecare Settings, and Others), and Spain Continuous Glucose Monitoring Market Insights, Industry Trend, Forecasts to 2033

Spain Continuous Glucose Monitoring Market Insights Forecasts to 2033

• The Spain Continuous Glucose Monitoring Market Size Was Valued at USD 57.24 Million in 2023.
• The Spain Continuous Glucose Monitoring Market Size is Growing at a CAGR of 10.19% from 2023 to 2033
• The Spain Continuous Glucose Monitoring Market Size is Expected to reach USD 151.05 Million by 2033

The Spain Continuous Glucose Monitoring Market Size is Anticipated to Exceed USD 151.05 Million by 2033, Growing at a CAGR of 10.19% from 2023 to 2033. The increasing prevalence of diabetes and technological advancements are driving the growth of the continuous glucose monitoring market in the Spain.     

Market Overview

The continuous glucose monitoring market refers to the industry providing devices and related services for continuously tracking blood glucose levels in real-time. Continuous glucose monitoring (CGM) is a device system used for automatically and continuously tracking blood glucose levels throughout the day and night. It is an effective way of managing diabetes in which drastic changes of blood glucose levels can be detected. The real-time data provided by the CGM system allows individuals to make more informed decisions about food, activity, and medication. The growing prevalence of diabetes, as well as the adoption of a sedentary lifestyle and an unhealthy diet, are significant factors that are responsible for driving the continuous glucose monitoring market. The increasing demand for advanced monitoring technologies, along with the upsurging emphasis on preventive healthcare, leads to promote the market growth. Innovation in the medical device industry with enhanced connectivity features such as wireless connectivity, personalized glucose level tracking, integration of insulin pumps, and AI & ML are creating growth opportunities in the continuous glucose monitoring market.

Report Coverage

This research report categorizes the market for the Spain continuous glucose monitoring market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the Spain continuous glucose monitoring market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the Spain continuous glucose monitoring market.

Driving Factors

The increasing prevalence of diabetes is responsible for driving the market demand. It was estimated that a total of 2,956,121 people were diagnosed with diabetes in Spain, which represents 6.66% of the population assigned to primary care in the Spanish national Health System. Technological advancements, including the smartphone integration for real-time measurement and self-monitoring lead to propel the market growth. In addition, the inclination towards preventive healthcare along with the introduction of new, advanced diabetes care devices leads to propelling the market growth.

Restraining Factors

The increased cost and limited reimbursement policies are challenging the continuous glucose monitoring market. Further, the limited adoption of the devices due to affordability barriers is negatively affecting the market.

Market Segmentation

The Spain continuous glucose monitoring market share is classified into device component and end-use.

• The sensors segment dominated the market with the largest revenue share in 2023 and is anticipated to witness significant CAGR growth during the forecast period.

The Spain continuous glucose monitoring market is segmented by device component into transmitters, sensors, and receivers. Among these, the sensors segment dominated the market with the largest revenue share in 2023 and is anticipated to witness significant CAGR growth during the forecast period. It includes the use of small, minimally invasive sensors for measuring glucose levels in the interstitial fluid. The increasing technological advancements for improved sensor accuracy is responsible for propelling the market growth in the sensors segment.

• The homecare settings segment held the largest revenue share in 2023 and is anticipated to witness the fastest CAGR growth during the forecast period.

The Spain continuous glucose monitoring market is segmented by end-use into hospitals, homecare settings, and others. Among these, the homecare settings segment held the largest revenue share in 2023 and is anticipated to witness the fastest CAGR growth during the forecast period. Continuous glucose monitoring in homecare settings offers real-time insights into blood glucose levels, which enables more informed decisions about patients' diet, activity, and insulin dosages. The efficiency and ease of monitoring blood glucose levels are driving the market demand in the homecare settings segment.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the Spain continuous glucose monitoring market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Abbott Laboratories
• Medtronic
• F. Hoffmann-La Roche Ltd.
• Ascensia Diabetes Care
• Insulet Corporation
• Menarini Diagnostics
• Insulcloud S.L.
• YPSOMED
• MicroTech Medical, Inc.
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at Spain, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the Spain Continuous Glucose Monitoring market based on the below-mentioned segments:

Spain Continuous Glucose Monitoring Market, By Device Component

• Transmitters
• Sensors
• Receivers

Spain Continuous Glucose Monitoring Market, By End-use

• Hospitals
• Homecare Settings
• Others